Artiva Biotherapeutics, Correlations

ARTV Stock   11.04  0.64  6.15%   
The current 90-days correlation between Artiva Biotherapeutics, and GAMCO Global Gold is 0.04 (i.e., Significant diversification). The correlation of Artiva Biotherapeutics, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Artiva Biotherapeutics, Correlation With Market

Significant diversification

The correlation between Artiva Biotherapeutics, Common and DJI is 0.08 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Artiva Biotherapeutics, Common and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Artiva Biotherapeutics, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Moving against Artiva Stock

  0.35PTN Palatin TechnologiesPairCorr
  0.51MOLN Molecular PartnersPairCorr
  0.45ABCL Abcellera BiologicsPairCorr
  0.39LPCN LipocinePairCorr
  0.38MNMD Mind MedicinePairCorr
  0.43TARS Tarsus PharmaceuticalsPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
AMPSEIC
GGN-PBPALT
FDUSSEIC
FDUSAMP
RMCOSEIC
AMPRMCO
  
High negative correlations   
GGN-PBSEIC
AMPPALT
AMPGGN-PB
SEICPALT
FDUSGGN-PB
RMCOPALT

Risk-Adjusted Indicators

There is a big difference between Artiva Stock performing well and Artiva Biotherapeutics, Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Artiva Biotherapeutics,'s multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Artiva Biotherapeutics, Corporate Management

David MoriartySenior OperationsProfile
Christopher HoranChief OfficerProfile
Thorsten MDChief OfficerProfile
Eugene HelselSenior AffairsProfile